Mannkind (MNKD) Net Cash Flow (2010 - 2026)
Mannkind (MNKD) reported Net Cash Flow of -$22.0 million for Q1 2026, down 2361.13% year-over-year from $975000.0 in Q1 2025, and up 58.01% quarter-over-quarter from -$52.5 million in Q4 2025.
Mannkind (MNKD) Net Cash Flow (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Net Cash Flow data on file, last reported at -$22.0 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$22.0 million, down 2361.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.5 million (up 103.81% YoY), and the FY2025 annual result was $28.6 million, up 114.92% from the prior year.
- Net Cash Flow advanced to -$22.0 million in Q1 2026 per MNKD's latest filing, from -$52.5 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $155.5 million in Q4 2023 and troughed at -$95.9 million in Q2 2024.
- A 5-year average of -$4.2 million and a median of -$3.2 million in 2023 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2024: Net Cash Flow surged 905.65% in 2023, then plunged 30543.49% in 2024.
- A 5-year view of Net Cash Flow shows it stood at $15.5 million in 2022, then surged by 905.65% to $155.5 million in 2023, then slumped by 110.31% to -$16.0 million in 2024, then slumped by 227.52% to -$52.5 million in 2025, then jumped by 58.01% to -$22.0 million in 2026.
- Business Quant data shows MNKD's Net Cash Flow at -$22.0 million in Q1 2026, -$52.5 million in Q4 2025, and $70.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -22.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.05 Mn |
| Mar 31, 2026 | -22.05 Mn |
| Dec 31, 2025 | -52.51 Mn |
| Dec 31, 2025 | -52.51 Mn |
| Sep 30, 2025 | 70.39 Mn |
| Sep 30, 2025 | 70.39 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Mar 31, 2025 | 975,000.00 |
| Mar 31, 2025 | 975,000.00 |
| Dec 31, 2024 | -16.03 Mn |
| Dec 31, 2024 | -16.03 Mn |
| Sep 30, 2024 | -34.27 Mn |
| Sep 30, 2024 | -34.27 Mn |
| Jun 30, 2024 | -95.90 Mn |
| Jun 30, 2024 | -95.90 Mn |
| Mar 31, 2024 | -45.21 Mn |
| Mar 31, 2024 | -45.21 Mn |
| Dec 31, 2023 | 155.46 Mn |
| Dec 31, 2023 | 155.46 Mn |